A hospital in Saudi Arabia announced today that it completed the world's first robotic-assisted implantation of the Abbott ...

The ARIES-HM3 substudy may help persuade implanters who are less well-versed in the circulatory changes an LVAD affords.

The left ventricular assist device market segment will reach $2.24bn by 2033. Abbott’s HeartMate 3 is the current market leader in the field and was approved by the FDA for less invasive ...

HeartMate 3 was implanted on a 35-year-old patient, who was out of the ICU in four days and should be discharged within 10 ...

The HeartMate II and HeartMate 3 are manufactured by Thoratec Corp., a subsidiary of Abbott Laboratories. About 14,000 of the ...

The HeartMate 3 LVAD (left ventricular assist device) is implanted in the chest and it helps pump blood from the lower left ...

Advt The Army Hospital (Research & Referral) has performed "India's first-ever Left Ventricular Assist Device (LVAD) implantation using the HeartMate 3 device in a government institution.

Army Hospital (Research & Referral), Delhi Cantt, has performed India's first-ever Left Ventricular Assist Device (LVAD) implantation using the HeartMate 3 device in a government institution.

Riyadh: King Faisal Specialist Hospital and Research Centre (KFSHRC) in Riyadh has successfully performed the world’s first ...

In a groundbreaking achievement, Army Hospital (Research & Referral), Delhi Cantt, has successfully performed India’s ...

KFSHRC performs the world’s first robotic-assisted artificial heart pump implantation, revolutionizing heart care with ...

King Faisal Specialist Hospital and Research Center (KFSHRC) in Riyadh has successfully performed the world’s first ...